FDA Import Refusal 310-9103849-2/1/1 — Celgene Cellular Therapeutics
The FDA refused shipment 310-9103849-2/1/1 from Celgene Cellular Therapeutics (United States) on Jul 18, 2003. The refused product falls under Drugs and Biologics — THALIDOMIDE (SEDATIVE). Cited charge: 179 This firm has 3 other import refusals on record.
Refusal details
- Date
- Jul 18, 2003
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 65VIY40 THALIDOMIDE (SEDATIVE)
- Charges
- 179